Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Increases By 23.4%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totaling 4,334 shares, a growth of 23.4% from the March 15th total of 3,511 shares. Based on an average daily volume of 11,274 shares, the days-to-cover ratio is presently 0.4 days.

Alpha Tau Medical Price Performance

Shares of DRTSW stock traded up $0.01 on Thursday, hitting $0.95. The stock had a trading volume of 39,182 shares, compared to its average volume of 48,261. The stock’s 50 day moving average is $1.02 and its 200-day moving average is $0.65. Alpha Tau Medical has a 52-week low of $0.18 and a 52-week high of $1.50.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.